4th iPSC Drug Development and Manufacturing Summit
Evvnt Promotion / evvnt
01.10.2024 - 03.10.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Kongressthemen
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder and Chief Scientific Officer, HebeCell, and more
URL:
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder and Chief Scientific Officer, HebeCell, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2453698-2?pid=4832
Herr Elliot Karmel
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
